| MolecularFormula: | C21H16ClF3N4O3•C7H8O3S |
| MolecularWeight: | 637.03g/mol |
| CASNumber: | 475207-59-1 |
| Appearance: | Offwhitepowder |
| Solubility: | solubleinDMSOat200mg/mL;verypoorlysolubleinethanol |
| Storage: | -20ºC |
| Purity: | ≥99% |
MaterialSafetyDataSheet
Date:Oct22,2015
1.PRODUCTANDCOMPANYIDENTIFICATION
1.1Productidentifier:
Productname:SorafenibTosylate
CatalogNo:1100203002,1100205002,1100200013,1100200023,1100200053
1.2Relevantidentifiedusesofthesubstanceormixtureandusesadvisedagainst
Forresearchuseonly.
1.3Detailsofthesupplierofthesafetydatasheet
Company:EtonBioscienceInc
TollFree:1-800-758-1630
Tel:1-800-758-1630
Fax:1-800-507-2912
1.4Emergencytelephonenumber
1-800-758-1630
2.HAZARDSIDENTIFICATION
2.1Classificationofthesubstanceormixture
Notadangeroussubstanceormixture
2.2GHSLabelelements,includingprecautionarystatements
Notadangeroussubstanceormixture
2.3Otherhazards
None
3.COMPOSITION/INFORMATIONONINGREDIENTS
3.1Substances
MolecularFormula:C21H16ClF3N4O3•C7H8O3S
MolecularWeight:637.03g/mol
CASNo:475207-59-1
4.FIRSTAIDMEASURES
4.1Descriptionoffirstaidmeasures
Eyecontact
Checkforandremovecontactlensesandflushwithcopiousamountsofwater;assureadequateflushingbyseparatingtheeyelidswithfingers;callaphysician
SkinContact
flushwithcopiousamountsofwater;removecontaminatedclothingandshoes;callaphysician
Inhalation
Ifinhaled,removetofreshair;ifbreathingisdifficult,giveoxygen;ifbreathingstops,giveartificialrespiration
Ingestion
ifswallowed,washoutmouthwithcopiousamountsofwater.DONOTinducevomiting.Callaphysician
4.2Mostimportantsymptomsandeffects,bothacuteanddelayed
Noinformationavailable
4.3Indicationofanyimmediatemedicalattentionandspecialtreatmentneeded.
Noinformationavailable
5.FIREFIGHTINGMEASURES
5.1Extinguishingmedia
Suitableextinguishingmedia
waterspray,carbondioxide,drychemicalpowderorfoam
5.2Specialhazardsarisingfromthesubstanceormixture
Noinformationavailable
5.3Adviceforfirefighters
Wearself-containedbreathingapparatusandprotectiveclothingtopreventcontactwithskinandeyes.
6.ACCIDENTALRELEASEMEASURES
6.1Personalprecautions,protectiveequipmentandemergencyprocedures
Usefullpersonalprotectiveequipment.Evacuatepersonneltosafeareas.
6.2Environmentalprecautions
Preventfurtherleakageorspillage.Preventproductfromenteringdrain.
6.3Methodsandmaterialforcontainmentandcleaningup
Absorbsolutionswithfinely-powderedliquid-bindingmaterial(diatomite,universalbinders);decontaminatesurfacesandequipmentbyscrubbingwithalcohol;disposeofcontaminatedmaterialaccordingtoSection13
7.HANDLINGANDSTORAGE
7.1Precautionsforsafehandling
Avoidskin/eyecontact.Useprotectiveequipmentasneeded.Washcontaminatedclothingbeforereuse.
7.2Conditionsforsafestorage,includinganyincompatibilities
Keepcontainertightlyclosedinacool,well-ventedplace.Storeat-20˚C.
7.3Specificenduse(s)
Nodataavailable.
8.EXPOSURECONTROLS/PERSONALINFORMATION
8.1ControlParameters
Thisproductcontainsnohazardousmaterialswithoccupationalexposurelimits.
8.2Exposurecontrols
Engineeringcontrols
Provideshowerandeyewashstation
Personalprotectiveequipment
EyeProtection | Wearsafetygoggles |
SkinProtection | Wearprotectiveclothing |
HandProtection | Wearprotectivegloves |
Respiratoryprotection | WearNIOSH/MSHAapprovedrespirators |
9.PHYSICALANDCHEMICALPROPERTIES
9.1Informationonbasicphysicalandchemicalproperties
Appearance | Solid |
pH | Nodataavailable |
Meltingpoint | Nodataavailable |
Freezingpoint | Nodataavailable |
Boilingpoint | Nodataavailable |
Density | Nodataavailable |
Watersolubility | Verypoorlysoluble |
9.2Othersafetyinformation
Nodataavailable.
10.STABILITYANDREACTIVITY
10.1Reactivity
Nodataavailable
10.2Chemicalstability
Stableunderrecommendedstorageconditions.
10.3Possibilityofhazardousreactions
Nodataavailable.
10.4Conditionstoavoid
Protectfromlightandheat
10.5IncompatIBLematerials
Strongoxidizingagents
10.6Hazardousdecompositionproducts
Thermaldecompositionmayproducetoxicgasessuchascarbonmonoxide,carbondioxide,andnitrogenoxides
11.TOXICOLOGICALINFORMATION
11.1Informationontoxicologicaleffects
Toxicologicaleffectsonthisproducthavenotbeenthoroughlystudied.
12.ECOLOGICALINFORMATION
12.1Toxicity
Avoidreleaseintoenvironment
12.2Persistenceanddegradability
Nodataavailable
12.3.Bioaccumlativepotential
Nodataavailable
12.4Mobilityinsoil
Nodataavailable
12.5ResultsofPBTandvPvBassessment
Nodataavailable
12.6Otheradverseeffects
Nodataavailable
13.DISPOSALINFORMATION
13.1Wastetreatmentmethods
Disposeinaccordancewithlocal,state,andfederalregulations.
14.TRANSPORTINFORMATION
DOT:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
IATA:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
IMDG:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
15.REGULATORYINFORMATION
EURiskandSafetyphrases:
R22:Harmfulifswallowed
S22:Donotbreathedust
S24/25:Avoidcontactwithskinandeyes
S26:Incaseofcontactwitheyes,rinseimmediatelywithplentyofwaterandseekmedicaladvice
S28:aftercontactwithskin,washimmediatelywithplentyofwater
S36/37/39:Wearsuitableprotectiveclothing,glovesandeye/faceprotection
16.OTHERINFORMATION
EulittPJ,ParkMA,HosseinH,CruikshanksN,YangC,DmitrievIP,YacoubA,CurielDT,FisherPB,DentP.Enhancingmda-7/IL-24therapyinrenalcarcinomacellsbyinhibitingmultipleprotectivesignalingpathwaysusingsorafenibandbyAd.5/3genedelivery.CancerBiolTher.2011Jan12;10(12):1290-305.Epub2010Dec15.
